Development Level

Tchem 4 | 1,890

Collection

Eligible Kinase Proteins 1 | 134

Disease

glioblastoma 4 | 5,572
psoriasis 4 | 6,685
Kidney disease 3 | 396
Status Epilepticus 3 | 85
Toxic encephalopathy 3 | 131
colon cancer 3 | 1,475
diabetes mellitus 3 | 1,663
lung cancer 3 | 4,466
lung carcinoma 3 | 2,844
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
pituitary cancer 3 | 1,972
Alzheimer's disease 2 | 644
Amphetamine-Related Disorders 2 | 74
Arthritis 2 | 248
Brain Ischemia 2 | 87
Brain disease 2 | 83
Cancer 2 | 2,346
Cerebrovascular disease 2 | 231
Eye disease 2 | 55
Heat Stroke 2 | 12
Hypertension 2 | 287
Juvenile arthritis 2 | 124
Liver carcinoma 2 | 217
Lung Neoplasms 2 | 171
Mammary Neoplasms 2 | 410
Morphine dependence 2 | 19
Obesity 2 | 616
Parkinson's disease 2 | 364
Reperfusion Injury 2 | 84
Rheumatoid Arthritis 2 | 1,160
Schizophrenia 2 | 501
Seizures 2 | 95
Waldenstrons macroglobulinemia 2 | 765
acute myeloid leukemia 2 | 780
acute quadriplegic myopathy 2 | 1,157
aldosterone-producing adenoma 2 | 664
astrocytic glioma 2 | 2,241
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
breast carcinoma 2 | 1,614
chronic lymphosyte leukemia 2 | 232
fibroadenoma 2 | 557
gastric cancer 2 | 430
group 4 medulloblastoma 2 | 1,875
hepatocellular carcinoma 2 | 532
inflammatory breast cancer 2 | 404
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
nephrosclerosis 2 | 329
nervous system disorder 2 | 53
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
periodontitis 2 | 269
primitive neuroectodermal tumor 2 | 3,031
pterygium 2 | 74
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Achalasia 1 | 11
Amnestic disorder 1 | 37
Amyotrophic Lateral Sclerosis 1 | 431
Anoxia 1 | 33
Anxiety Disorders 1 | 37
Atherosclerosis 1 | 275
Cocaine-Related Disorders 1 | 88
Colonic Neoplasms 1 | 126
Depressive disorder 1 | 48
Diabetes Mellitus, Insulin-Dependent 1 | 76
Down syndrome 1 | 548
Epilepsy 1 | 346
Heart disease 1 | 279
Hepatic encephalopathy 1 | 25
Hyperalgesia 1 | 71
Hypertensive disease 1 | 193
Hypoglycemia 1 | 81
Impotence 1 | 45
Irritable bowel syndrome 1 | 59
Liver disease 1 | 219
Liver neoplasms 1 | 109
Lung disease 1 | 132
Muscular dystrophy 1 | 48
Narcolepsy 1 | 58
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Osteopetrosis 1 | 40
Osteoporosis 1 | 257
Pain agnosia 1 | 99
Parkinson Disease 1 | 102
Peripheral Neuropathy 1 | 303
Portal hypertension 1 | 21
Stomach Neoplasms 1 | 282
Sudden infant death syndrome 1 | 33
Vascular disease 1 | 281
adrenocortical carcinoma 1 | 1,427
atypical teratoid/rhabdoid tumor 1 | 1,095
cystic fibrosis 1 | 1,665
fascioscapulohumeral muscular dystrophy 1 | 100
medulloblastoma 1 | 1,524
pancreatic carcinoma 1 | 567
post-traumatic stress disorder 1 | 45
tuberculosis and treatment for 3 months 1 | 327

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Transcription Factor 2 | 1,400
Enzyme 1 | 4,146
Kinase 1 | 634

Grant Application

5F31AA015472-03 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
Cyclin-dependent kinase-like 1 CDKL1 Tchem Kinase -0.66241 5.41 233
Nitric oxide synthase, brain NOS1 Tchem Enzyme -3.25683 1820.9 523
Transcription factor AP-1 JUN Tchem Transcription Factor -3.80760 5981.8 2262